DK0529410T3 - Antibiotikum GE 2270 faktor C2a - Google Patents
Antibiotikum GE 2270 faktor C2aInfo
- Publication number
- DK0529410T3 DK0529410T3 DK92113732.9T DK92113732T DK0529410T3 DK 0529410 T3 DK0529410 T3 DK 0529410T3 DK 92113732 T DK92113732 T DK 92113732T DK 0529410 T3 DK0529410 T3 DK 0529410T3
- Authority
- DK
- Denmark
- Prior art keywords
- antibiotic
- factor
- medicament
- directed
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Glass Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP91114667 | 1991-08-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0529410T3 true DK0529410T3 (da) | 1998-05-11 |
Family
ID=8207101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92113732.9T DK0529410T3 (da) | 1991-08-30 | 1992-08-12 | Antibiotikum GE 2270 faktor C2a |
Country Status (9)
Country | Link |
---|---|
US (1) | US5514649A (de) |
EP (1) | EP0529410B1 (de) |
JP (1) | JP3122248B2 (de) |
KR (1) | KR100249871B1 (de) |
AT (1) | ATE163428T1 (de) |
CA (1) | CA2077102C (de) |
DE (1) | DE69224497T2 (de) |
DK (1) | DK0529410T3 (de) |
ES (1) | ES2113391T3 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0451486T3 (da) * | 1990-03-08 | 1995-05-08 | Lepetit Spa | Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T |
US5882900A (en) * | 1992-09-10 | 1999-03-16 | Gruppo Lepetit S.P.A. | Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium |
DK0808326T3 (da) * | 1995-02-07 | 2001-10-01 | Biosearch Italia Spa | Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika |
DK0801655T3 (da) * | 1995-02-07 | 1999-02-08 | Biosearch Italia Spa | Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika |
JP2000505438A (ja) * | 1996-02-14 | 2000-05-09 | バイオサーチ・イタリア・ソチエタ・ペル・アチオニ | 抗生物質GE2270因子C▲下2a▼、D▲下2▼およびEの誘導体 |
PE20080103A1 (es) * | 2006-05-31 | 2008-04-03 | Novartis Ag | AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu |
US8183341B2 (en) * | 2006-12-20 | 2012-05-22 | Novartis Ag | Antibacterial compounds and processes for its production |
BRPI0812340A2 (pt) * | 2007-06-04 | 2015-01-27 | Novartis Ag | Macrociclos e seus usos |
CN101945866B (zh) | 2007-12-12 | 2013-06-19 | 诺瓦提斯公司 | 氨基噻唑化合物及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5202241A (en) * | 1988-09-09 | 1993-04-13 | Gruppo Lepetit S.P.A. | Antibiotic GE 2270 |
GB8821160D0 (en) * | 1988-09-09 | 1988-10-12 | Lepetit Spa | Antibiotic ge 2270 |
ES2066914T3 (es) * | 1989-07-04 | 1995-03-16 | Lepetit Spa | Factores a1, a2, a3 y h del antibiotico ge 2270. |
DK0451486T3 (da) * | 1990-03-08 | 1995-05-08 | Lepetit Spa | Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T |
IL100572A (en) * | 1991-01-03 | 1997-01-10 | Lepetit Spa | Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them |
-
1992
- 1992-08-12 DE DE69224497T patent/DE69224497T2/de not_active Expired - Fee Related
- 1992-08-12 ES ES92113732T patent/ES2113391T3/es not_active Expired - Lifetime
- 1992-08-12 DK DK92113732.9T patent/DK0529410T3/da active
- 1992-08-12 EP EP92113732A patent/EP0529410B1/de not_active Expired - Lifetime
- 1992-08-12 AT AT92113732T patent/ATE163428T1/de not_active IP Right Cessation
- 1992-08-20 JP JP04244216A patent/JP3122248B2/ja not_active Expired - Fee Related
- 1992-08-28 CA CA002077102A patent/CA2077102C/en not_active Expired - Fee Related
- 1992-08-29 KR KR1019920015636A patent/KR100249871B1/ko not_active IP Right Cessation
-
1995
- 1995-04-21 US US08/428,787 patent/US5514649A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3122248B2 (ja) | 2001-01-09 |
DE69224497D1 (de) | 1998-04-02 |
ES2113391T3 (es) | 1998-05-01 |
CA2077102C (en) | 2002-11-12 |
EP0529410B1 (de) | 1998-02-25 |
KR930004471A (ko) | 1993-03-22 |
EP0529410A2 (de) | 1993-03-03 |
CA2077102A1 (en) | 1993-03-01 |
ATE163428T1 (de) | 1998-03-15 |
KR100249871B1 (ko) | 2000-03-15 |
DE69224497T2 (de) | 1998-07-02 |
JPH0649087A (ja) | 1994-02-22 |
EP0529410A3 (en) | 1993-05-26 |
US5514649A (en) | 1996-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0473084A3 (en) | Polyethylene glycol derivatives, their modified peptides, methods for producing them and use of the modified peptides | |
KR920017655A (ko) | 상처의 치료를 촉진시키기 위한 약학 조성물 | |
DK0529410T3 (da) | Antibiotikum GE 2270 faktor C2a | |
IL81106A (en) | Antibiotic composition containing a 40926 n-acyl-aminoglucuronyl aglycon and a 40926 aglycon,process for their preparation and pharmaceutical compositions containing them | |
DK0406745T3 (da) | Antibiotiske GE 2270 faktorer A1, A2, A3 og H | |
FI933681A (fi) | Antimikrobiellt medel | |
DK0451486T3 (da) | Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T | |
ATE141605T1 (de) | Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen | |
ATE114154T1 (de) | Thienotriazolodiazepine und ihre pharmazeutische verwendung. | |
KR890001534A (ko) | 항균제 fr109615 및 이의 제조방법 | |
ES2112517T3 (es) | Antibioticos ge 37468 a, b y c. | |
ATE144780T1 (de) | Megakaryocytopoietischer faktor | |
EP0359062A3 (de) | Antibiotikum GE 2270 | |
ATE117725T1 (de) | Antibiotikum ge1655-komplex und seine faktoren a,b und c. | |
ATE173921T1 (de) | Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen | |
DE68906437D1 (de) | L-pyroglutamyl-l-cystein-dipeptid mit hoher anti-cataractogener wirkung und dies enthaltende pharmazeutische zusammensetzungen. | |
DK0674645T3 (da) | Cephemforbindelser med antimikrobiel virkning | |
RU93048568A (ru) | 14,14,14-трифтор-12-оксатетрадекановая кислота, липидный ингибитор вируса иммунодефицита человека |